Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial

Autor: John A, Dormandy, Bernard, Charbonnel, David J A, Eckland, Erland, Erdmann, Massimo, Massi-Benedetti, Ian K, Moules, Allan M, Skene, Meng H, Tan, Pierre J, Lefèbvre, Gordon D, Murray, Eberhard, Standl, Robert G, Wilcox, Lars, Wilhelmsen, John, Betteridge, Kåre, Birkeland, Alain, Golay, Robert J, Heine, László, Korányi, Markku, Laakso, Marián, Mokán, Antanas, Norkus, Valdis, Pirags, Toomas, Podar, André, Scheen, Werner, Scherbaum, Guntram, Schernthaner, Ole, Schmitz, Jan, Skrha, Ulf, Smith, Jan, Taton, T D M, Williams

Publikováno v: Dormandy, J A, Charbonnel, B, Eckland, D J, Erdmann, E, Massi-Benedetti, M, Moules, I K, Skene, A M, Tan, M H, Lefebvre, P J, Murray, G D, Standl, E & Wilcox, R G 2005, ' Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial ', Lancet, vol. 366, no. 9493, pp. 1279-1289 . https://doi.org/10.1016/S0140-6736(05)67528-9
Dormandy, J A, Charbonnel, B, Eckland, D J, Erdmann, E, Massi-Benedetti, M, Moules, I K, Skene, A M, Tan, M H, Lefebvre, P J, Murray, G D, Standl, E, Wilcox, R G, Wilhelmsen, L, Betteridge, J, Birkeland, K, Golay, A, Heine, R J, Koranyi, L, Laakso, M, Mokan, M, Norkus, A, Pirags, V, Podar, T, Scheen, A, Scherbaum, W, Schernthaner, G, Schmitz, O, Skrha, J, Smith, U & Taton, J 2005, ' Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial ', The Lancet, vol. 366(9493), pp. 1279-1289 .
Lancet, 366(9493), 1279-1289. Elsevier Limited

Patients with type 2 diabetes are at high risk of fatal and non-fatal myocardial infarction and stroke. There is indirect evidence that agonists of peroxisome proliferator-activated receptor gamma (PPAR gamma) could reduce macrovascular complications

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7c2b925ba490c64f541b2f444a756d92
https://doi.org/10.1016/s0140-6736(05)67528-9

Increasing incidence of childhood-onset Type I diabetes in 3 Baltic countries and Finland 1983–1998

Autor: A Solntsev, J. Tuomilehto, Toomas Podar, M. Viik-Kajander, Girts Brigis, Zilvinas Padaiga, Matti K. Karvonen, Antti Reunanen, B. Urbonaite

Publikováno v: Diabetologia. 44:B17-B20

We aimed to study the incidence of Type I diabetes in 4 countries, Estonia, Latvia, Lithuania and Finland, during 1983-1998, focusing on the two separate periods of 1983-1990 and 1991-1998.Population-based incidence data from nationwide diabetes regi

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7cf25c2c3a392dabc67a62e8b22f0a76
https://doi.org/10.1007/pl00002947

Mortality in patients with childhood-onset type 1 diabetes in Finland, Estonia, and Lithuania: follow-up of nationwide cohorts

Autor: Rimas Zalinkevicius, B. Urbonaite, Toomas Podar, Ronald E. LaPorte, J. Tuomilehto, A Solntsev, Matti K. Karvonen, Antti Reunanen

Publikováno v: Diabetes Care. 23:290-294

OBJECTIVE: To assess mortality of population-based cohorts of childhood-onset type 1 diabetic patients from the Eastern European countries of Estonia and Lithuania and compare this information with recent data from Finland. RESEARCH DESIGN AND METHOD

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0bd9f62f03314f32b7d1078338cb8513
https://doi.org/10.2337/diacare.23.3.290

Incidence and prevalence of Type 1 (insulin-dependent) diabetes in Estonia in 1988

Autor: Toomas Podar, I Kalits

Publikováno v: Diabetologia. 33:346-349

The objective of this study was to determine the incidence and prevalence of Type 1 (insulin-dependent) diabetes in Estonia in different sex and age groups. The data collection was based on a centralized retrospective registration of all cases of Typ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b72f207e20c8fa68596d6f5bb125b4c1
https://doi.org/10.1007/bf00404638

The role of angiotensin converting enzyme inhibitors and angiotensin II receptor antagonists in the management of diabetic complications

Autor: Toomas Podar, Jaakko Tuomilehto

Publikováno v: Drugs. 62(14)

Evidence suggests that ACE inhibitors can be advantageous for prevention and halting progression of both micro- and macrovascular complications in patients with diabetes mellitus. ACE inhibitors are useful antihypertensive agents in both type 1 and t

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::860237d76d41ab518b31df213c3c9da0
https://pubmed.ncbi.nlm.nih.gov/12269846